The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -7.92 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M -3.22 — no flag raisedOK
- Earnings quality 68/100 — worth a closer lookWatch
Where the revenue comes from
Fiscal 2025, as Cosmos Health Inc. reports it. History and quarterly detail are in the app.
- Wholesale$59.3M
- Nutraceuticals and Pharmaceuticals$4.3M
- Pharma manufacturing$1.7M
- Other$1K
Leadership changes
From Cosmos Health Inc.'s own filings, the day they're filed.
- Theodoros C. Karkantzos · director · appointmenteff. 2025-09-30
- Pavlos Ignatiades · Chief Communications Officer · departureeff. 2023-09-20
Latest filings
- 8-K · Company announcement2026-08-20
- 10-Q · Quarterly report2026-08-18
- 8-K · Company announcement2026-07-16
- 8-K · Company announcement2026-07-06
- DEF 14A · Annual proxy (pay & governance)2026-06-02
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Cosmos Health Inc., every answer cited to the official filings🔒
- The Intelligence Brief — added when Cosmos Health Inc.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.